TRAIL activates a death-inducing signaling complex (DISC) assembly mechanism that is analogous to that of the Fas pathway by binding to the Death Receptor 4 (DR4) and Death Receptor 5 (DR5), which are highly expressed in tumor cells (Yuan et al., 2018). The gene discussed is TNFRSF10A; the disease is neoplasm.